|
|
MarketView
Events defining the day's trading activity on Wall Street
Lauren Rudd
Monday, March 22, 2010
Summary
If there is one thing that the financial markets
dislike, it is uncertainty and on Monday the uncertainty regarding the
healthcare bill in Congress was over sending share prices higher and the
major equity indexes into positive territory. After initially trading
lower, the Dow Jones industrial average rebounded to finish at a
17-month high and its ninth gain in 10 sessions. Although there were some concerns over whether the
bill, approved on Sunday would hurt profits within the industry, for all
practical purposes this was already priced into share prices. For
example, among the pharmaceutical companies, Pfizer added 1.4 percent to
close at $17.15 while Merck & was up 0.6 percent to close at $38.30.
Both companies are Dow components. Insurance companies were mixed, with WellPoint down
1.1 percent to $64.39 and Aetna up 0.5 percent, closing at $34.64.
Molina Healthcare, which stands to gain from the extension of Medicaid
benefits, rose 3.6 percent to $25.33. Among the large cap stocks, Boeing ended the day up
1.9 percent, closing at $72.04 after Barclays raised its price target on
the plane manufacturer. Large cap tech stocks sent the Nasdaq to its
highest close since August 2008. Oracle ended the day up 1.8 percent to
close at $25.65. The business software maker is scheduled to report
results later this week. Apple ended the day up 1.2 percent, closing at
$224.87 Google edged 0.4 percent lower to $557.95. Earlier it
said visitors to its China search engine are being redirected to the
Hong Kong-based engine following unsuccessful talks with the Chinese
government about operating an uncensored search engine in the country. Surprisingly, Tiffany reported a fourth-quarter
profit that was weaker than expected but gave a full-year profit view
that was above consensus. The stock fell 0.3 percent to close at $47.41.
Health Care Bill Does Not Daunt Interest Shares of Medicaid insurers, hospital companies and
even drug manufacturers rose on Monday as Wall Street began to realize
that that passage of the landmark healthcare legislation will add
millions of new paying patients. Shares of hospital companies, such as Community
Health Systems and health insurers such as Amerigroup that focus on
Medicaid plans for the poor, led the rise as the reform package extends
coverage to 32 million Americans. The overhaul will expand the Medicaid government
health plan for the poor and bar insurance practices such as refusing to
cover people with pre-existing medical conditions. Shares of health insurers, the prime target of
reformers during the lengthy debate rose as uncertainty was cleared from
the market in that they had avoided a worst-case scenario, specifically
the creation of a government-run competitor. Meanwhile, the large
insurers, such as WellPoint and UnitedHealth Group shed early gains,
while Medicaid-focused insurers such as Amerigroup and Molina Healthcare
climbed sharply because they stand to benefit from an expansion of the
program. Molina shares were up 5 percent. However, the cost of protecting health insurers' debt
with credit default swaps rose.Five-year credit default swaps on Aetna
rose to 110.5 basis points from 97.5 basis points at Friday's close,
while Cigna Corp's (CI.N) credit default swaps rose to 120 basis points
from 110 basis points on Friday, according to data from CMA DataVision. Shares of hospital companies were higher. For
example, Community Health Systems and Tenet Healthcare rose 4 percent
and 7.7 percent, respectively. The overhaul has been seen as helping
hospital companies by adding more insured customers, thereby decreasing
the numbers of patients who used services without being able to pay for
them. Drug companies face new fees, but wider insurance
coverage could help offset the costs by delivering new customers willing
to fill costly prescriptions. Medtronic and Boston Scientific also face
an industry tax, but it was cut in half to $20 billion and will not
start until 2013.
|
|
|
MarketView for March 22
MarketView for Monday, March 22